Karolinska Development AB - ESG Rating & Company Profile powered by AI
This page includes a Q&A section about Karolinska Development AB. Full Sustainability analysis of Karolinska Development AB can be reached by registering for free. Alternative companies in the scoring peer group for Karolinska Development AB are shownin the table.
Karolinska Development AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 2.7, social score of 4.8 and governance score of 6.0.
4.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
852 | Vaccibody AS | 4.6 | High |
852 | argenx SE | 4.6 | High |
868 | Karolinska Development AB | 4.5 | High |
868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
868 | Boiron SA | 4.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Karolinska Development AB have an accelerator or VC vehicle to help deliver innovation?
Does Karolinska Development AB disclose current and historical energy intensity?
Does Karolinska Development AB report the average age of the workforce?
Does Karolinska Development AB reference operational or capital allocation in relation to climate change?
Does Karolinska Development AB disclose its ethnicity pay gap?
Does Karolinska Development AB disclose cybersecurity risks?
Does Karolinska Development AB offer flexible work?
Does Karolinska Development AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Karolinska Development AB disclose the number of employees in R&D functions?
Does Karolinska Development AB conduct supply chain audits?
Does Karolinska Development AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Karolinska Development AB conduct 360 degree staff reviews?
Does Karolinska Development AB disclose the individual responsible for D&I?
Does Karolinska Development AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Karolinska Development AB disclose current and / or historical scope 2 emissions?
Does Karolinska Development AB disclose water use targets?
Does Karolinska Development AB have careers partnerships with academic institutions?
Did Karolinska Development AB have a product recall in the last two years?
Does Karolinska Development AB disclose incidents of discrimination?
Does Karolinska Development AB allow for Work Councils/Collective Agreements to be formed?
Has Karolinska Development AB issued a profit warning in the past 24 months?
Does Karolinska Development AB disclose parental leave metrics?
Does Karolinska Development AB disclose climate scenario or pathway analysis?
Does Karolinska Development AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Karolinska Development AB disclose the pay ratio of women to men?
Does Karolinska Development AB support suppliers with sustainability related research and development?
Does Karolinska Development AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Karolinska Development AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Karolinska Development AB involved in embryonic stem cell research?
Does Karolinska Development AB disclose GHG and Air Emissions intensity?
Does Karolinska Development AB disclose its waste policy?
Does Karolinska Development AB report according to TCFD requirements?
Does Karolinska Development AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Karolinska Development AB disclose energy use targets?
Does Karolinska Development AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Karolinska Development AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Karolinska Development AB
These potential risks are based on the size, segment and geographies of the company.
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.